Patents by Inventor Steven H. Zuckerman

Steven H. Zuckerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inhibiting autoimmune diseases
    Patent number: 6436958
    Abstract: A method of inhibiting auto immune diseases comprising administering to a human in need thereof an effective amount of a compound having the formula wherein R1 and R3 are independently hydrogen, —CH3, or wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: August 20, 2002
    Assignee: Eli Lilly and Company
    Inventor: Steven H. Zuckerman
  • Methods of increasing macrophage function
    Patent number: 5672610
    Abstract: A method of increasing macrophage function comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.Also encompassed by the invention is a method of treating immunocompromissed individuals comprising administering a compound of formula 1.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: September 30, 1997
    Assignee: Eli Lilly and Company
    Inventor: Steven H. Zuckerman
  • Methods of inhibiting autoimmune diseases
    Patent number: 5521198
    Abstract: A method of inhibiting autoimmune diseases comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: May 28, 1996
    Assignee: Eli Lilly and Company
    Inventor: Steven H. Zuckerman
  • Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
    Patent number: 5447941
    Abstract: A method of inhibiting pulmonary hypertensive disease comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: September 5, 1995
    Assignee: Eli Lilly and Company
    Inventor: Steven H. Zuckerman